Edwards Lifesciences
739 hedge funds and large institutions have $19.3B invested in Edwards Lifesciences in 2017 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 270 increasing their positions, 258 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
739
Holders Change
+19
Holders Change %
+2.64%
% of All Funds
18.45%
Holding in Top 10
10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-28.57%
% of All Funds
0.25%
New
82
Increased
270
Reduced
258
Closed
55
Calls
$79.4M
Puts
$111M
Net Calls
-$31.4M
Net Calls Change
-$15K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$147M |
| 2 |
BlackRock
New York
|
+$106M |
| 3 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$88M |
| 4 |
NSLI
Nan Shan Life Insurance
Taipei City,
Taiwan
|
+$66.7M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$62.3M |
Top Sellers
| 1 |
Brown Advisory
Baltimore,
Maryland
|
-$107M |
| 2 |
HM
HealthCor Management
New York
|
-$94.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$79.4M |
| 4 |
FAM
Fred Alger Management
New York
|
-$65.6M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$65.3M |
